It is a pharma private limited company based in Nashik, Maharashtra, India, established in 2015.
2015 | Nashik, Maharashtra, India | ActiveKupvit Pharmaceutical Private Limited, a active private limited company, was established on 18 August 2015 in Nashik, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2015PTC267545. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mangesh Prabhakar Gaikwad (Additional Director), Kunal Rajendra Sanklecha (Additional Director). Past directors included Parashuram Balanath Gaike, Prabhakar Onkar Gaikwad, Suvarna Parag Deshmukh. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Flat No. 05, Vrundavan Pride, Vrindavan Nagar,\\, Nashik, Maharashtra, 422008.
U74999MH2015PTC267545
267545
18 August 2015
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kupvit Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mangesh Prabhakar Gaikwad | Additional Director | 22 Mar 2023 | Current |
| Kunal Rajendra Sanklecha | Additional Director | 22 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Nov 2018 | Past |
| Pramod Abcsdd | Director | 23 Mar 2023 | Past |
| Pramod Abcsdd | Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Director | 23 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kupvit Pharmaceutical Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 15.83% decrease. The company also saw a substantial improvement in profitability, with a 105.52% increase in profit. The company's net worth moved up by a moderate rise of 2.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Kupvit Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kupvit Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kupvit Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kupvit Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mangesh Prabhakar Gaikwad was appointed as a Additional Director was appointed as a Additional Director on 22 Mar 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.
Kunal Rajendra Sanklecha was appointed as a Additional Director was appointed as a Additional Director on 22 Mar 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.
Progress on Kupvit Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Kupvit Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was recorded as a recent event.
Kupvit Pharmaceutical Private Limited was registered on 18 Aug 2015 with Roc Mumbai & aged 10 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Kupvit Pharmaceutical Private Limited is U74999MH2015PTC267545.
Kupvit Pharmaceutical Private Limited is headquartered at Flat No. 05, Vrundavan Pride, Vrindavan Nagar,\\, Nashik, Maharashtra, 422008.
Kupvit Pharmaceutical Private Limited was incorporated on 18 August 2015.
The current directors of Kupvit Pharmaceutical Private Limited are
The primary industry of Kupvit Pharmaceutical Private Limited is Trade.
Kupvit Pharmaceutical Private Limited is unlisted.
The authorized capital of Kupvit Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Kupvit Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX